A COVID vaccine for kids

More than half a year has passed since the first vaccine for COVID-19 was given emergency authorization, and almost half the United States has protection against the SARS-CoV-2 virus as a result. Yet children under the age of 12, for whom the

The long view on COVID-19 vaccine safety and efficacy

Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more

Need for more rapid diagnostics for COVID-19

The FINANCIAL — More accurate rapid diagnostics for COVID-19 are being developed using an isothermal test that simultaneously detects two gene targets. The tests are being developed by the i-sense group at University College London (UCL).

Long COVID Cases Under-Reported in NHS GP Records

The FINANCIAL -- Using the full pseudonymised GP records of 57.9 million patients in England, researchers at Oxford University and the London School of Hygiene and Tropical Medicine have found that formally recorded diagnoses of Long COVID are substantially lower than previous

1 2 3 27